Erlotinib and asthenia 
Erlotinib and asthenia Patient Reports February 11, 2012
Erlotinib Side Effects Report #5500207-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Female patient, weighting 124.0 lb, was diagnosed with tongue cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, fatigue, pain
, pneumonia aspiration. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5455928-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 30, 2007. Female patient was diagnosed with pulmonary mass and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clavicle fracture, disease progression, fall
, fatigue, pain . Erlotinib dosage: 150 MG (QD, ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LEVAQUIN, POTASSIUM CHLORIDE, NEULASTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5420772-7
Erlotinib side effect was reported by a Physician from CANADA on Aug 01, 2007. Female patient, 69 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clostridial infection, decreased appetite, failure to thrive, fatigue, haemoglobin decreased, oral intake reduced. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, BEVACIZUMAB, CRESTOR, GLYBURIDE, METFORMIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5764810-0
Erlotinib side effect was reported by a Physician from UNITED STATES on May 19, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, ascites, asthenia, blood albumin decreased, candidiasis, confusional state, dehydration, failure to thrive. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient died on 05/17/2008.
Erlotinib Side Effects Report #5243827-9
Erlotinib side effect was reported by a Physician from GERMANY on Jan 31, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, inflammation, leukocytosis. Erlotinib dosage: 100 MG (QD); ORAL. During the same period patient was treated with GEMCITABINE. Patient died.
Erlotinib Side Effects Report #5888935-4
Erlotinib side effect was reported by a Physician from GERMANY on Sept 02, 2008. Female patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, OXYCODONE, METOCLOPRAMIDE, SPRINOLACONTE, ENOXAPARIN, OMEPRAZOLE. Patient was hospitalized. Patient died on 04/15/2008.
Erlotinib Side Effects Report #5268193-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, weighting 205.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, heart rate increased, pyrexia, respiratory rate increased. Erlotinib dosage: 150 MG ONCE A DAY PO. During the same period patient was treated with XELODA, PANCREASE, PREVACID, ZOLOFT, IMODIUM, ZOFRAN, LOMOTIL, TINCTURE OF OPIUM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5731478-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 22, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, hyperglycaemia, hyponatraemia, pyrexia, white blood cell count increased. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5822141-4
Erlotinib side effect was reported by a Physician from AUSTRIA on July 10, 2008. Female patient, 79 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, catheter site infection, dehydration, dysphagia, nervous system disorder, parkinsonism, performance status decreased, speech disorder, urticaria. Erlotinib dosage: 150 MG (150 MG, QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DIGIMERCK, PANTOPRAZOLE, LASIX, DURAGESIC, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5942619-2
Erlotinib side effect was reported by a Physician from AUSTRIA on Oct 17, 2008. Female patient, 79 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, central line infection, dehydration, dysphagia, hypoglycaemia, parkinsonism, performance status decreased, progressive supranuclear palsy
. Erlotinib dosage: 150 MG (150 MG,QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DIGIMERCK, PANTOPRAZOLE, LASIX, DURAGESIC, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4812003-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Female patient, weighting 158.7 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, coagulopathy, culture urine positive, dehydration, depression
, dizziness , lactobacillus infection, liver function test abnormal, nausea . Erlotinib dosage: 150MG/PER DAY BY MOUTH. During the same period patient was treated with BEVACIZUMAB, COUMADIN, PAXIL, DOXYCYCLINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5877487-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Male patient, 72 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anorexia, asthenia, atrial flutter, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, sinus tachycardia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, BACTRIM, ALBUTEROL, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
Erlotinib Side Effects Report #5779170-9
Erlotinib side effect was reported by a Physician from UNITED STATES on June 02, 2008. Female patient, 67 years of age, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal discomfort, aortic stenosis, asthenia, atrial fibrillation
, dehydration, dizziness , gait disturbance, hiccups, hypotension. Erlotinib dosage: 100 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, GLIPIZIDE, BENAZEPRIL, PLAVIX, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5808287-5
Erlotinib side effect was reported by a Physician from UNITED STATES on June 02, 2008. Female patient, 67 years of age, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal discomfort, aortic stenosis, asthenia, atrial fibrillation
, dehydration, dizziness , ejection fraction decreased, gait disturbance, hiccups. Erlotinib dosage: (100 MG), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, GLIPIZIDE, BENAZEPRIL, PLAVIX, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5518470-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5638851-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5839955-7
Erlotinib side effect was reported by a Physician from UNITED STATES on July 23, 2008. Female patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, respiratory failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died on 07/18/2008.
Erlotinib Side Effects Report #5748902-8
Erlotinib side effect was reported by a Physician from AUSTRALIA on May 07, 2008. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation
, blood calcium decreased, blood glucose increased, blood urea increased, dehydration, emphysema, lymphangitis, syncope. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, PREDNISOLONE, DIAMICRON, COTAZYM, LOFENOXAL, CLONAZEPAM, METOCLOPRAMIDE, ASPIRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5719902-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 14, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anaemia, anorexia, asthenia, blood creatinine increased, blood pressure decreased, bronchial carcinoma, cardio-respiratory arrest, dehydration. Erlotinib dosage: (150 MG,QD),ORAL; 9100 MG, QD), ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.Erlotinib Side Effects Report #5250757-5
Erlotinib side effect was reported by a Physician from GERMANY on Feb 09, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain
, constipation , dehydration, disease progression, fall , infection . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5634112-1
Erlotinib side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain
, constipation , dehydration, disease progression, fall , infection , nausea . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5339603-9
Erlotinib side effect was reported by a Physician from UNITED STATES on May 10, 2007. Male patient, 73 years of age, weighting 191.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, asthenia, body temperature decreased, cerebral atrophy, chest x-ray abnormal, clostridium difficile colitis, diastolic dysfunction, disease progression, emphysema. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MEGACE, DUONEB, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5163210-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 10, 2006. Male patient, 73 years of age, weighting 191.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, blood glucose increased, body temperature decreased, cerebral atrophy, clostridium difficile colitis, diastolic dysfunction, emphysema, encephalopathy, haemoglobin decreased. Erlotinib dosage: 100 MG (QD) ORAL. During the same period patient was treated with BEVACIZUMAB, MEGACE, DUONEB, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5463845-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Male patient, 73 years of age, weighting 191.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, asthenia, body temperature decreased, cerebral atrophy, chest x-ray abnormal, clostridium difficile colitis, diastolic dysfunction, disease progression, emphysema. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MEGACE, DUONEB, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5400121-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 27, 2007. Female patient, 71 years of age, weighting 148.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abasia, asthenia, back pain
, constipation , dehydration, diarrhoea, failure to thrive, hypokalaemia. Erlotinib dosage: 150 MG QD PO. Patient died on 07/24/2007.Erlotinib Side Effects Report #5688185-0
Erlotinib side effect was reported by a Physician from ITALY on Mar 14, 2008. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, delirium. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5732114-8
Erlotinib side effect was reported by a Health Professional from ITALY on Apr 21, 2008. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, delirium, myocardial infarction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MORPHINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5093284-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2006. Male patient, 68 years of age, weighting 125.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, hyperhidrosis, loss of consciousness, performance status decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 07/03/2006.
Erlotinib Side Effects Report #6120798-4
Erlotinib side effect was reported by a Physician from BRAZIL on Feb 26, 2009. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, hypertension, rash
, skin infection. Erlotinib dosage: 150 MG (150 MG,QD), ORAL. During the same period patient was treated with OMEPRAZOLE, DEXAMETHASONE, NYSTATIN, METOCLOPRAMIDE, MORPHINE. Patient was hospitalized. Patient died on 07/12/2005.Erlotinib Side Effects Report #5328191-9
Erlotinib side effect was reported by a Physician from PHILIPPINES on Apr 27, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dizziness
. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4896286-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, bacteraemia, blood calcium decreased, blood sodium decreased, breath sounds abnormal, cardio-respiratory arrest, chest discomfort. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, ASPIRIN, LOVENOX, ADVAIR DISKUS, ALBUTEROL INHALER, MS CONTIN, PERCOCET, SIMETHICONE. Patient died on 11/01/2005.
Erlotinib Side Effects Report #5765510-3
Erlotinib side effect was reported by a Physician from PHILIPPINES on May 22, 2008. Male patient, 63 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5828487-8
Erlotinib side effect was reported by a Physician from PHILIPPINES on July 15, 2008. Male patient, 63 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5194056-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient, 61 years of age, weighting 125.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blood bicarbonate increased, blood calcium decreased, blood creatinine increased, blood glucose increased, blood potassium increased, blood pressure systolic decreased, blood sodium decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with VELCADE, WARFARIN, NEXIUM, LIPITOR, COLACE, ZESTRIL, DILANTIN, RANITIDINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5814317-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 03, 2008. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, chromaturia, dyspepsia, gastrooesophageal reflux disease, herpes zoster, hypophagia, hypovolaemia, radiation oesophagitis, skin lesion. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5814317-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 03, 2008. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, chromaturia, dyspepsia, gastrooesophageal reflux disease, herpes zoster, hypophagia, hypovolaemia, radiation oesophagitis, skin lesion. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5955949-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 27, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, candidiasis, confusional state, cough, dehydration, dysphagia, electrolyte imbalance, mental status changes. Erlotinib dosage: (50 MG, QD), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4928113-6
Erlotinib side effect was reported by a Physician from SWITZERLAND on Feb 21, 2006. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dizziness
, fall , pulmonary embolism . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DEXAMETHASONE. Patient died.Erlotinib Side Effects Report #5196407-8
Erlotinib side effect was reported by a Health Professional from SPAIN on Dec 11, 2006. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety
, asthenia, band neutrophil count increased, cardiac output decreased, coordination abnormal, disease progression, malaise, mediastinal shift, myalgia. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with OMEPRAZOLE, DEXAMTHASONE, ANALGESICS, MORPHINE. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #4677230-7
Erlotinib side effect was reported by a Physician from on May 16, 2005. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, chest pain
, dizziness , dyspnoea, fall . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DEXAMETHASONE. Patient died on 05/05/2005.Erlotinib Side Effects Report #5409385-0
Erlotinib side effect was reported by a Physician from PHILIPPINES on July 23, 2007. Female patient, 34 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, neutropenia, stomatitis, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5442907-2
Erlotinib side effect was reported by a Physician from PHILIPPINES on Aug 15, 2007. Female patient, 34 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, mucosal inflammation, neutropenia, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5494757-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Female patient, weighting 180.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6052696-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 05, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, hepatic neoplasm malignant, jaundice
, oedema peripheral, productive cough. Erlotinib dosage: (150 MG) ,ORAL. Patient died.Erlotinib Side Effects Report #6106518-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 17, 2009. Female patient, weighting 205.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, blood pressure decreased, carotid artery disease
, depressed level of consciousness, lung neoplasm malignant, malignant neoplasm progression, metastases to liver. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with COMPLETE VITAMINS, ACTOS, LOW DOSE ASA, ZETIA, VITAMIN B12. Patient died.Erlotinib Side Effects Report #5527205-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 07, 2007. Female patient, 79 years of age, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, ataxia
, atelectasis, blood chloride increased, blood sodium decreased, blood urea increased, cardiac disorder, constipation , dehydration. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient died.Erlotinib Side Effects Report #5320159-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 18, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, myalgia, nuclear magnetic resonance imaging abnormal, platelet count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5351039-3
Erlotinib side effect was reported by a Physician from UNITED STATES on May 21, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, myalgia. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5174252-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 20, 2006. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, fatigue, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, TYLENOL, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5450729-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, ACETAMINOPHEN, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578433-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 10, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, blood sodium decreased, blood urea increased, blood urea nitrogen/creatinine ratio increased, breath sounds abnormal, constipation
, dehydration, diarrhoea, dysphagia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5715252-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 08, 2008. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with metastatic neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acth stimulation test abnormal, asthenia, blood glucose increased, blood thyroid stimulating hormone increased, cerebral atrophy, eye rolling, haematocrit increased, haemoglobin decreased, orthostatic hypotension. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, FLOVENT, SYNTHROID, ASPIRIN, NIASPAN, VYTORIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5081403-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 28, 2006. Female patient, 56 years of age, weighting 211.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, asthenia, chromaturia, gallbladder disorder, hepatomegaly, hyperhidrosis, hypotension, metastases to liver, nausea
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5567677-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Male patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, nausea
. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5909730-3
Erlotinib side effect was reported by a Physician from FRANCE on Sept 09, 2008. Female patient, 78 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dermatitis acneiform, folliculitis, inflammation, rash papular, rash pustular. Erlotinib dosage: unknown. During the same period patient was treated with ATARAX, VASTAREL, LOVENOX. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5839448-7
Erlotinib side effect was reported by a Physician from GERMANY on July 23, 2008. Female patient, 63 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, fluid intake reduced, hypophagia, skin exfoliation. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with FORADIL, PULMICORT. Patient died on 06/06/2008.
Erlotinib Side Effects Report #5232502-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Female patient, weighting 119.0 lb, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, metastases to bone. Erlotinib dosage: 150 MG DAILY ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died on 02/04/2007.
Erlotinib Side Effects Report #5782718-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 04, 2008. Female patient, weighting 280.0 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dehydration, granulocytes abnormal, neutrophil count decreased, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5320144-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 18, 2007. Female patient, 75 years of age, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clavicle fracture, condition aggravated, fall
, fatigue, pain . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LEVAQUIN, POTASSIUM, NEULASTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5194441-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Male patient, 45 years of age, weighting 175.5 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, diarrhoea, fatigue, haemoglobin decreased, nausea , neutrophil count decreased, oedema, ureteric obstruction. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ATENOLOL, ATIVAN, DECADRON, EMEND, INSULIN, LISINOPRIL, LOVENOX. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4814847-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Male patient, weighting 154.3 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, confusional state, dehydration, diarrhoea, failure to thrive, laboratory test interference, orthostatic hypotension. Erlotinib dosage: 100MG QD ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5125290-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 67 years of age, weighting 163.8 lb, was diagnosed with carcinoid tumour and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, anorexia, asthenia, chest pain , confusional state, dehydration, diarrhoea, fatigue. Erlotinib dosage: unknown. During the same period patient was treated with GLYBURIDE, FERROUS SULPHATE, KEPPRA, LORTAB, SANDOSTATIN, ZOMETA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5237875-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 25, 2007. Female patient, 51 years of age, weighting 215.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, asthenia, gastrointestinal disorder, metastases to liver. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5189804-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2006. Female patient, 51 years of age, weighting 215.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, asthenia, fatigue. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5196418-2
Erlotinib side effect was reported by a Physician from FRANCE on Dec 18, 2006. Female patient, 16 years of age, was diagnosed with brain stem glioma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, convulsion, intracranial pressure increased, tumour haemorrhage. Erlotinib dosage: unknown. During the same period patient was treated with OMEPRAZOLE, NEURONTIN, PREDNISOLONE, BETAHISTINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5423120-1
Erlotinib side effect was reported by a Physician from FRANCE on Aug 06, 2007. Female patient, 16 years of age, was diagnosed with brain neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, intracranial pressure increased, tumour haemorrhage. Erlotinib dosage: 225 MG,ORAL ; 125 MG,ORAL ; 150 MG;ORAL. During the same period patient was treated with MOPRAL, NEURONTIN, SOLUPRED, BETAHISTINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5643837-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anaemia, anorexia, asthenia, blood creatinine increased, dehydration, dermal cyst, failure to thrive, gastrointestinal haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL, 100 MG, QD, ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.Erlotinib Side Effects Report #5677827-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anaemia, anorexia, asthenia, blood creatine increased, blood urea increased, cardio-respiratory arrest, dehydration, dermal cyst. Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.Erlotinib Side Effects Report #5056097-1
Erlotinib side effect was reported by a Physician from SPAIN on June 28, 2006. Male patient, 70 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, disorientation, mental disorder, respiratory tract infection. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with FRUMILTE, DIGOXIN, ALDACTACINE, CIMAL, TRAMADOL. Patient recovered.